Recent systematic review and analysis by He et al. [48] showed that high protein expression of LC3B predicted adverse overall survival in breast cancer (HR = 1.98, 95% CI = 1.25–3.13), however, none of the studies included in this meta-analysis specified the pattern of LC3B staining in tumor samples. Here, MAP1LC3B is linked to breast carcinoma.